{"slug":"vip-glp1-gut","verification":{"valid":true,"entries":2,"head":"da9c46b13888f53aa97a24eff52365f641fa04bde4c488bf29c5a37073cd8a34"},"energy":{"passes":2,"tokens_in":16064,"tokens_out":3003,"tokens_total":19067,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"da9c46b13888f53aa97a24eff52365f641fa04bde4c488bf29c5a37073cd8a34"},"provenance":[{"ts":"2026-06-29T22:31:09.080Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Glp1 Gut\nSlug: vip-glp1-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"GLP-1 gut damage / gastroparesis\",\"condition_key\":\"glp1-gut-damage\",\"primary_peptide\":\"vip\",\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have GLP-1 gut damage / gastroparesis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"glp1-agonists\",\"name\":\"GLP-1 agonists (class)\",\"section_title\":\"Why GLP-1 agonists (class) matters for you\",\"steps\":[\"**Drug:** GLP-1 agonists (class)\",\"**What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\",\"**Therefore for you:** state whether this drug **reduces load","response":"{\n  \"slug\": \"vip-glp1-gut\",\n  \"title\": \"VIP Peptide and GLP-1 Agonist Gut Effects: Evidence on Motility and Repair Layers\",\n  \"body\": \"## What's breaking down if you have GLP-1 gut damage / gastroparesis\\n\\nGLP-1 agonists slow gastric emptying as a known mechanism. If your gut motility slows too much, food stays in the stomach longer. This can lead to bloating, nausea, and in some cases symptoms that resemble gastroparesis. The enteric nervous system and smooth muscle layers handle coordinated contractions. When these signals weaken or inflammation rises, repair pathways may lag behind the ongoing stress from the drug. VIP acts as a signaling molecule in the gut wall. It supports smooth muscle relaxation and fluid secretion. If your issue traces to slowed motility or enteric nerve signaling, that layer sits upstream of symptom persistence.\\n\\n## Why VIP might help you\\n\\nYou are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\\n\\nTherefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain. Step 1: GLP-1 slows emptying via direct receptor effects on the stomach. Step 2: If enteric VIP pathways are under-active or stressed, adding VIP may support the relaxation phase of peristalsis in preclinical models. Step 3: This could allow better coordination of contractions over time rather than continued suppression. The logic stays at the immune/autonomic layer where VIP receptors sit on gut neurons and immune cells.\\n\\n## Why GLP-1 agonists (class) matters for you\\n\\nDrug: GLP-1 agonists (class). What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss. Therefore for you: This drug suppresses a motility signal. The suppression helps blood sugar control and appetite but trades off against normal gastric emptying speed. If your gastroparesis-like symptoms started or worsened on the drug, the tradeoff sits in the sam","tokens_in":16064,"tokens_out":3003,"cost":0,"prev":"genesis","hash":"60d85b8fb55b5eb0e777bd4f5b7333312bc4ca975375fa5993795f8e1453a8a9"},{"ts":"2026-07-17T02:43:24.048Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-glp1-gut","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"60d85b8fb55b5eb0e777bd4f5b7333312bc4ca975375fa5993795f8e1453a8a9","hash":"da9c46b13888f53aa97a24eff52365f641fa04bde4c488bf29c5a37073cd8a34"}]}